ARLINGTON, Va., Oct. 14 /PRNewswire/ --  BioInformatics, LLC announces the pending release of three Q4 market reports:

RNAi:  Product Usage & Brand Assessment (#10-006)

Exploring Structural Biology:  Tools & Techniques Used in the Study of Membrane Protein Structure (#10-004)

Genomic Technologies:  Market Insights for Life Science Suppliers (#10-005)

In an effort to support suppliers who provide product and services to these three rapidly growing markets, BioInformatics is publishing three titles in the fourth quarter of 2010.  Given the accelerated changes in each of these technologies, these three reports provide suppliers up-to-date primary research that identifies trends, planned expenditures and anticipated growth.

RNAi:  Product Usage & Brand Assessment (#10-006)

Scheduled for release on October 15, 2010, this report will provide market insights and analysis to suppliers of products and services that support RNAi experiments. By using this report, RNAi product suppliers will gain an understanding of where scientists predict the future of RNAi technologies is headed so as to better anticipate current and upcoming RNAi product needs.

In this report, scientists indicate planned instrument and consumable purchases by vendor.  The following suppliers were provided as some of the choices in the survey:

Abnova

Affymetrix (NASDAQ: AFFX)

Agilent Technologies (NYSE: A)

Ambion

B-Bridge

Bioneer

Biosettia

Bio-Rad (NYSE: BIO)

Cellecta

Cell Signaling Technology

Clontech

Dharmacon

EMD Millipore

Eurofins MWG Operon

Exiqon

GeneCopoeia

Genosensor

Hamilton Life Science Robotics

Imgenex

ImaGenes

Integrated DNA Technologies

InvivoGen

LC Sciences

Life Technologies (NasdaqGS: LIFE)

Luminex (NASDAQ: LMNX)

Miltenyi Biotech

MWG Biotech

OligoEngine

Open Biosystems

OriGene

OZ Biosciences

Promega

Qiagen (NasdaqGS: QGEN)

Santa Cruz Biotechnology

Sigma-Aldrich (NASDAQ: SIAL)

System Biosciences

Exploring Structural Biology:  Tools & Techniques Used in the Study of Membrane Protein Structure (#10-004)

Due out at the end of October, this study was designed to provide membrane structural biology product suppliers with critical insights as to technologies and areas of research with the highest potential for rapid growth. Recent technological advancements and the introduction of computational approaches to the analysis of membrane components have brought new life to membrane structural biology, and this report provides a roadmap for suppliers who seek to explore new market opportunities.

Scientists provide insights as to planned instrument and consumable purchases by vendor.  The following suppliers were provided as some of the choices in the survey:

Abcam

Active Motif

Agilent Technologies (NYSE: A)

Amersham Biosciences (GE Healthcare)

Anasazi Instruments

Bio-Rad (NYSE: BIO)

BioVision

Bruker (NASDAQ: BRKR)

Buchi

Clontech

Dionex (NASDAQ: DNEX)

EMD Millipore

Fermentas Life Sciences

Flowgen Bioscience

GE Healthcare (NYSE: GE)

Hitachi (NYSE: HIT)

Imgenex

JASCO

JEOL

Life Technologies (NasdaqGS: LIFE)

Miltenyi Biotec

New England Biolabs

PerkinElmer (NYSE: PKI)

Promega

Qiagen (NasdaqGS: QGEN)

Shimadzu (Tokyo: 7701)

Sigma-Aldrich (NASDAQ: SIAL)

Teledyne Isco (NYSE: TDY)

Thermo Fisher Scientific (NYSE:  TMO)

Varian

Wang NMR

Waters Corporation (NYSE: WAT)

Genomic Technologies:  Market Insights for Life Science Suppliers (#10-005)

This report is for life science suppliers who want to respond in a timely fashion to the rapidly changing market for genomic analysis products. In this study, BioInformatics LLC quantifies and characterizes the market for genetic analysis including those products used for genome-wide association studies (GWAS), copy number variation (CNV) analysis, genotyping and techniques such as microarrays, sequencing and real-time PCR.

Delivery is scheduled for mid-November.

Survey respondents indicate planned lab expenditures by vendor.  The following suppliers were provided as some of the choices in the survey:

Agilent Technologies (NYSE: A)

Affymetrix (NASDAQ: AFFX)

Beckman Coulter (NYSE: BEC)

BD Biosciences (NYSE: BDX)

Bioneer

Bio-Rad (NYSE: BIO)

BioTrove

Cepheid (NASDAQ: CPHD)

Eppendorf

GE Healthcare (NYSE: GE)

Helicos Bioscience (NASDAQ: HLCS)

Idaho Technology, Inc.

Illumina (NASDAQ: ILMN)

Li-Cor Biosciences

Life Technologies (NasdaqGS: LIFE)

Luminex (NASDAQ: LMNX)

Qiagen (NasdaqGS: QGEN)

Roche Applied Science

Sequenom (NASDAQ: SQNM)

Stratagene

Techne (NASDAQ: TECH)

 "RNAi, genomics and membrane protein structures are three fast-growing markets in the life science industry," states Tamara Zemlo, Ph.D., MPH, Vice President of Advisory Services.  Dr. Zemlo adds that "Suppliers are challenged to keep up with the ever-changing demands of researchers involved in this type of cutting edge research."

To learn more about these reports, complimentary Executive Summaries are available at

http://www.gene2drug.com/reports/210/

http://www.gene2drug.com/reports/208/

http://www.gene2drug.com/reports/209/

ABOUT BIOINFORMATICS, LLC

BioInformatics, LLC is the premier research and advisory firm serving the life science industry.  By leveraging our professional social network of more than 50,000 biomedical researchers, we have supported more than 300 companies and provided insights that lead to better business decisions.  Our assignments include assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=50555

SOURCE BioInformatics, LLC